Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Cash Flow-to-Debt Ratio
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥69.15 Million could theoretically repay 0% of its total liabilities (CN¥2.84 Billion) in one year. See Anhui Fengyuan Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Anhui Fengyuan Pharmaceutical Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see Anhui Fengyuan Pharmaceutical Co Ltd cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year debt coverage analysis for Anhui Fengyuan Pharmaceutical Co Ltd. Check 000153 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥119.30 Million | CN¥2.93 Billion | ▼ -14.5% |
| 2024 | 0.05x | CN¥126.24 Million | CN¥2.65 Billion | ▼ -53.8% |
| 2023 | 0.10x | CN¥254.75 Million | CN¥2.47 Billion | ▼ -36.4% |
| 2022 | 0.16x | CN¥439.99 Million | CN¥2.71 Billion | ▲ +53.9% |
| 2021 | 0.11x | CN¥237.88 Million | CN¥2.26 Billion | ▼ -21.3% |
| 2020 | 0.13x | CN¥292.75 Million | CN¥2.19 Billion | ▲ +351.1% |
| 2019 | 0.03x | CN¥66.21 Million | CN¥2.23 Billion | ▼ -78.2% |
| 2018 | 0.14x | CN¥233.59 Million | CN¥1.72 Billion | ▲ +301.9% |
| 2017 | 0.03x | CN¥52.40 Million | CN¥1.55 Billion | ▼ -42.1% |
| 2016 | 0.06x | CN¥78.21 Million | CN¥1.34 Billion | ▲ +44.1% |
| 2015 | 0.04x | CN¥45.50 Million | CN¥1.12 Billion | ▲ +321.1% |
| 2014 | 0.01x | CN¥10.51 Million | CN¥1.09 Billion | ▲ +112.7% |
| 2013 | -0.08x | CN¥-70.31 Million | CN¥926.72 Million | ▼ -212.3% |
| 2012 | 0.07x | CN¥45.65 Million | CN¥675.47 Million | ▼ -32.1% |
| 2011 | 0.10x | CN¥55.06 Million | CN¥552.99 Million | ▼ -5.6% |
| 2010 | 0.11x | CN¥55.04 Million | CN¥522.02 Million | ▲ +71.4% |
| 2009 | 0.06x | CN¥32.41 Million | CN¥526.78 Million | ▼ -36.8% |
| 2008 | 0.10x | CN¥49.82 Million | CN¥511.47 Million | ▼ -20.7% |
| 2007 | 0.12x | CN¥55.26 Million | CN¥449.73 Million | ▲ +50.8% |
| 2006 | 0.08x | CN¥36.27 Million | CN¥445.10 Million | ▲ +15.2% |
| 2005 | 0.07x | CN¥34.88 Million | CN¥493.08 Million | ▲ +284.0% |
| 2004 | -0.04x | CN¥-11.72 Million | CN¥304.86 Million | ▲ +46.0% |
| 2003 | -0.07x | CN¥-11.46 Million | CN¥160.93 Million | ▼ -184.0% |
| 2002 | 0.08x | CN¥10.48 Million | CN¥123.55 Million | ▼ -37.6% |
| 2001 | 0.14x | CN¥23.57 Million | CN¥173.33 Million | ▼ -46.3% |
| 2000 | 0.25x | CN¥25.88 Million | CN¥102.28 Million | ▲ +1939.0% |
| 1999 | 0.01x | CN¥1.01 Million | CN¥81.65 Million | — |